| Christopher H Ward, MD | |
|
1995 Errecart Blvd Ste 103, Elko, NV 89801-8336 | |
| (775) 738-3111 | |
| (775) 778-6728 |
| Full Name | Christopher H Ward |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 47 Years |
| Location | 1995 Errecart Blvd Ste 103, Elko, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417012998 | NPI | - | NPPES |
| 5339 | Other | NV | MEDICAL BOARD |
| CS03886 | Other | NV | STATE PHARMACY |
| 002004007 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 5339 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeastern Nevada Regional Hospital | Elko, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hogle Miller And Ward Professional Corporation | 8022908375 | 2 |
News Archive
A breakthrough for brain tumor drug development and personalized medicine published today in Nature Scientific Reports.
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today reported operational and financial results for the second quarter ended June 30, 2015.
NeuroSigma, Inc., a Los Angeles-based medical technology company, announced today that it has signed a contract with the University of California, Los Angeles (UCLA) to fund a Phase I pediatric clinical trial to study the use of non-invasive, external Trigeminal Nerve Stimulation (TNS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
A study led by Dr. Keisuke Kondo at the Research Institute of Economy, Trade and Industry, Japan, has recently developed a mathematical model to investigate the impacts of interregional mobility restriction on the transmission of SARS-CoV-2.
Some medical and behavioral treatments show promise for reducing certain behaviors in children with autism spectrum disorders, but more research is needed to assess the potential benefits and harms, according to a new report funded by HHS' Agency for Healthcare Research and Quality. The research results were published online in the journal Pediatrics.
› Verified 1 days ago
| Entity Name | Hogle Miller & Ward Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720144579 PECOS PAC ID: 8022908375 Enrollment ID: O20040318001523 |
News Archive
A breakthrough for brain tumor drug development and personalized medicine published today in Nature Scientific Reports.
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today reported operational and financial results for the second quarter ended June 30, 2015.
NeuroSigma, Inc., a Los Angeles-based medical technology company, announced today that it has signed a contract with the University of California, Los Angeles (UCLA) to fund a Phase I pediatric clinical trial to study the use of non-invasive, external Trigeminal Nerve Stimulation (TNS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
A study led by Dr. Keisuke Kondo at the Research Institute of Economy, Trade and Industry, Japan, has recently developed a mathematical model to investigate the impacts of interregional mobility restriction on the transmission of SARS-CoV-2.
Some medical and behavioral treatments show promise for reducing certain behaviors in children with autism spectrum disorders, but more research is needed to assess the potential benefits and harms, according to a new report funded by HHS' Agency for Healthcare Research and Quality. The research results were published online in the journal Pediatrics.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher H Ward, MD 1995 Errecart Blvd Ste 103, Elko, NV 89801-8336 Ph: (775) 738-3111 | Christopher H Ward, MD 1995 Errecart Blvd Ste 103, Elko, NV 89801-8336 Ph: (775) 738-3111 |
News Archive
A breakthrough for brain tumor drug development and personalized medicine published today in Nature Scientific Reports.
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today reported operational and financial results for the second quarter ended June 30, 2015.
NeuroSigma, Inc., a Los Angeles-based medical technology company, announced today that it has signed a contract with the University of California, Los Angeles (UCLA) to fund a Phase I pediatric clinical trial to study the use of non-invasive, external Trigeminal Nerve Stimulation (TNS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
A study led by Dr. Keisuke Kondo at the Research Institute of Economy, Trade and Industry, Japan, has recently developed a mathematical model to investigate the impacts of interregional mobility restriction on the transmission of SARS-CoV-2.
Some medical and behavioral treatments show promise for reducing certain behaviors in children with autism spectrum disorders, but more research is needed to assess the potential benefits and harms, according to a new report funded by HHS' Agency for Healthcare Research and Quality. The research results were published online in the journal Pediatrics.
› Verified 1 days ago
John A Tyburczy, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1995 Errecart Blvd Ste 103, Elko, NV 89801 Phone: 775-738-3111 Fax: 775-778-6728 | |
Elizabeth Tom, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1995 Errecart Blvd Ste 103, Elko, NV 89801 Phone: 775-738-3111 Fax: 775-778-6728 | |
Mr. Robert W Brownlee Ii, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1780 Browning Way, Suite A, Elko, NV 89801 Phone: 775-777-1046 Fax: 775-777-1862 | |
Dr. Andrew Phillips Rogers, MD Surgery Medicare: Medicare Enrolled Practice Location: 2102 Idaho Street, Elko, NV 89801 Phone: 775-389-5777 |